These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3575746)

  • 1. Rational drug therapy of the hyperlipoproteinemias, Part I.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Sep; 20(9):1-7. PubMed ID: 3575746
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent aspects of diagnosis and treatment of lipoprotein disorders. Impact on prevention of atherosclerotic diseases. Proceedings of an international symposium. Vienna, August 21-23, 1986.
    Prog Clin Biol Res; 1988; 255():1-383. PubMed ID: 3340633
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis and treatment of lipoprotein disorders.
    Stacpoole P
    Compr Ther; 1989 Apr; 15(4):28-44. PubMed ID: 2650981
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
    Bossini A; Pirro C; Barba C
    Clin Ter; 1984 Sep; 110(5):417-28. PubMed ID: 6238757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperlipoproteinemias, diet and drug therapy. Risk of arteriosclerosis and the lipoproteins].
    Schwandt P
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):447-8. PubMed ID: 6769012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipoproteins and arteriosclerosis].
    Ras Monleón RM
    Med Clin (Barc); 1985 Nov; 85(16):664-6. PubMed ID: 4079562
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipoproteinaemia and xanthomatosis as a model of cholesterol ester accumulation.
    Vermeer BJ
    J Dermatol; 1986 Feb; 13(1):2-9. PubMed ID: 3522689
    [No Abstract]   [Full Text] [Related]  

  • 8. Xanthomas and the inherited hyperlipoproteinemias in children and adolescents.
    Maher-Wiese VL; Marmer EL; Grant-Kels JM
    Pediatr Dermatol; 1990 Sep; 7(3):166-73. PubMed ID: 2123340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects of xanthomatosis and hyperlipoproteinemia.
    Vermeer BJ; Gevers Leuven J
    Curr Probl Dermatol; 1991; 20():63-72. PubMed ID: 1935220
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertriglyceridemia].
    Tokita Y; Oikawa S; Kotake H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():505-7. PubMed ID: 11347121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 12. [Familial aspects of xanthomatosis].
    Oriente Biondi C
    G Ital Dermatol Minerva Dermatol; 1969 Aug; 44(8):412-8. PubMed ID: 5408931
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chylomicronemia syndrome complicating type 1 hyperlipoproteinemia with concomitant insulin-dependent diabetes].
    Wojtukiewicz MZ; Lemancewicz D; Dziecioł J; Chrostek L
    Pol Merkur Lekarski; 1999 Feb; 6(32):84-6. PubMed ID: 10337179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipoproteinemia: epidemiology, pathogenesis, clinical symptoms, significance for the pathogenesis of arteriosclerosis].
    Haller H
    Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):640-5. PubMed ID: 7434801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autoimmune chylomicronemia--pathogenesis and pathophysiology].
    Matsuzawa Y; Kihara S; Kubo M; Tarui S
    Nihon Rinsho; 1990 Jun; 48(6):1344-50. PubMed ID: 2200900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of lipolytic enzymes in the physiopathology of plasma lipoprotein metabolism].
    Szeszko A; Lutz W
    Pol Tyg Lek; 1982 Jul; 37(22):657-61. PubMed ID: 6757901
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple firm, painless erythematous papules with a yellowish hue.
    Otto AI; Horvath I; Feldmann J
    Arch Dermatol; 2005 Dec; 141(12):1595-600. PubMed ID: 16365265
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.